Jonathan Liss News Today

Food and Drug Administration approved Leqembi last year

(Repeats to additional subscribers with no changes to text ) By Julie Steenhuysen CHICAGO (Reuters) -Nine months into the U.S. launch of the first drug proven to slow the advance of Alzheimer's, Eisai and Biogen's Leqembi is facing an unexpected hurdle...

Nine months into the U.S. launch of the first drug proven to slow the advance of Alzheimers, Eisai and Biogens Leqembi is facing an unexpected hurdle to widespread use: an entrenched belief among some doctors that treating the memory-robbing disease is futile.

CHICAGO (Reuters) -Nine months into the U.S. launch of the first drug proven to slow the advance of Alzheimer's, Eisai and Biogen's Leqembi is facing an unexpected hurdle to widespread use: an entrenched belief among some doctors that treating the memory-robbing disease is futile. Alzheimer's experts had anticipated bottlenecks due to Leqembi's requirements, which include additional diagnostic tests, twice-monthly infusions and regular brain scans to guard against potentiall...

The adoption of the FDA-approved Alzheimer's drug, Leqimbi, has slowed down in the U.S. as more experts grow hesitant about the drugs cost, risks and efficacy.

The Carter Center announced former First Lady Rosalynn Carter had been diagnosed with dementia, and many questions are arising about the illness, treatment and its possible impact on mental health.

For Georgians living with early stage Alzheimer’s, hope has turned once again to a new drug being touted as a game-changer.

Steven and Bonnie Salomon of Decatur have been married 54 years.